Search review questions

Neonatal hypoglycaemia · pregnant women with pre‐existing type 1 diabetes

Gestational weight gain · pregnant women with pre‐existing type 1 diabetes

Childhood/adulthood adiposity · pregnant women with pre‐existing type 1 diabetes

Childhood/adulthood diabetes · pregnant women with pre‐existing type 1 diabetes

Childhood/adulthood neurosensory disability · pregnant women with pre‐existing type 1 diabetes

Postnatal depression · pregnant women with pre‐existing type 1 diabetes

Induction of labour · pregnant women with pre‐existing type 1 diabetes

Later development of cardiovascular disease · pregnant women with pre‐existing type 1 diabetes

Large‐for‐gestational age · pregnant women with pre‐existing type 1 diabetes

Perinatal mortality · pregnant women with pre‐existing type 1 diabetes

Miscarriages · women with idiopathic hyperprolactinemia and recurrent miscarriage history

Live births · women with idiopathic hyperprolactinemia and recurrent miscarriage history

Conception · women with idiopathic hyperprolactinemia and recurrent miscarriage history

Proportion reduction in serum prolactin levels · women with idiopathic hyperprolactinemia and recurrent miscarriage history

Serum prolactin normalization · women with idiopathic hyperprolactinemia and recurrent miscarriage history

Adverse maternal effects · women with idiopathic hyperprolactinemia and recurrent miscarriage history

Adverse fetal outcomes · women with idiopathic hyperprolactinemia and recurrent miscarriage history

Extended perinatal mortality · pregnant women at less than 36 weeks' gestation in whom there is clinical suspicion of fetal compromise

Serious neonatal morbidity (composite outcome including bronchopulmonary dysplasia (BPD), necrotising enterocolitis (NEC), intraventricular haemorrhage (IVH), retinopathy of prematurity (ROP), hypoxic ischaemic encephalopathy (HIE) · pregnant women at less than 36 weeks' gestation in whom there is clinical suspicion of fetal compromise

Death or disability at or after 2 years · pregnant women at less than 36 weeks' gestation in whom there is clinical suspicion of fetal compromise

Caesarean section · pregnant women at less than 36 weeks' gestation in whom there is clinical suspicion of fetal compromise

Infant admission to neonatal intensive care or special care facility · pregnant women at less than 36 weeks' gestation in whom there is clinical suspicion of fetal compromise

Respiratory distress syndrome (as defined by trialists) · pregnant women at less than 36 weeks' gestation in whom there is clinical suspicion of fetal compromise

Use of pharmacological pain relief/anaesthesia · pregnant women

Satisfaction with pain relief (number of women who reported that they felt they had adequate pain relief) · pregnant women

Satisfaction with pain relief (reported 2 weeks postnatal) ‐ Pethidine Seven‐point scale: 7 = most satisfaction · pregnant women

Satisfaction with pain relief (reported 2 weeks postnatal) ‐ Entenox Seven‐point scale: 7 = most satisfaction · pregnant women

Satisfaction with pain relief (reported 2 weeks postnatal) ‐ Self‐hypnosis Seven‐point scale: 7 = most satisfaction · pregnant women

Satisfaction with pain relief (reported 2 weeks postnatal) ‐ Epidural Seven‐point scale: 7 = most satisfaction · pregnant women

Satisfaction with pain relief (reported 2 weeks postnatal) ‐ Water immersion Seven‐point scale: 7 = most satisfaction · pregnant women

Coping in labour · pregnant women

Spontaneous vaginal birth · pregnant women

Perinatal mortality · preterm prelabour rupture of membranes (PPROM)

Preterm birth less than 37 weeks' gestation · preterm prelabour rupture of membranes (PPROM)

Neonatal sepsis · preterm prelabour rupture of membranes (PPROM)

Chorioamnionitis (as defined in individual trials) · preterm prelabour rupture of membranes (PPROM)

Respiratory distress syndrome (as defined in individual trials) · preterm prelabour rupture of membranes (PPROM)

Postpartum endometritis/other sepsis · preterm prelabour rupture of membranes (PPROM)

Neonatal death (death within the first 28 days of life) · preterm prelabour rupture of membranes (PPROM)

Preterm birth less than 37 weeks' gestation · preterm prelabour rupture of membranes (PPROM)

Neonatal sepsis · preterm prelabour rupture of membranes (PPROM)

Respiratory distress syndrome (as defined in individual trials) · preterm prelabour rupture of membranes (PPROM)

Chorioamnionitis (as defined in individual trials) · preterm prelabour rupture of membranes (PPROM)

Postpartum endometritis/other sepsis · preterm prelabour rupture of membranes (PPROM)

Perinatal mortality · preterm prelabour rupture of membranes (PPROM)

Neonatal death (death within the first 28 days of life) · preterm prelabour rupture of membranes (PPROM)

Maternal death · patients with sickle cell disease in pregnancy

Severe maternal morbidity (pulmonary embolism) · patients with sickle cell disease in pregnancy

Severe maternal morbidity (congestive cardiac failure) · patients with sickle cell disease in pregnancy

Perinatal death · patients with sickle cell disease in pregnancy